Leap Therapeutics, Inc. (LPTX) Financials

LPTX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 72.8 million 12.7 million
2023-09-30 83.0 million 11.0 million
2023-06-30 95.9 million 11.8 million
2023-03-31 106.5 million 78.2 million

LPTX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -10.4 million 1.3 million
2023-09-30 -10.5 million 1.3 million
2023-06-30 -10.2 million 1.3 million
2023-03-31 -12.7 million 1.3 million

LPTX Net Income

No data available :(

LPTX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 70.6 million - 262000
2023-09-30 80.7 million - 369000
2023-06-30 91.4 million - 474000
2023-03-31 102.0 million - 577000

LPTX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 27.0 million
2023-09-30 27.0 million
2023-06-30 14.7 million
2023-03-31 12.9 million

LPTX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 11.7 million 3.1 million 110000
2023-09-30 - 11.5 million 3.3 million -
2023-06-30 348000 11.1 million 3.6 million -
2023-03-31 348000 38.9 million 3.8 million -

LPTX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 634000 110000
2023-09-30 - 107000
2023-06-30 - 106000
2023-03-31 - 104000

LPTX

Price: $3.19

52 week price:
1.24
10.20

Earnings Per Share: -3.98 USD

P/E Ratio: -0.73

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 72793

Ebitda: -6.8 million

Market Capitalization: 65.0 million

Links: